JAMMU, Dec 24: The Jammu and Kashmir Medical Supplies Corporation Limited (JKMSCL) has issued an urgent directive to halt the use of Bupivacaine Hydrochloride in Dextrose Injection USP (0.5%), 5mg/ml, 4ml ampoule, Batch Number AA40222, manufactured by Aishwarya Healthcare Ltd.
The decision to stop the vaccine was taken after an Adverse Drug Reaction (ADR) was reported concerning this batch, which was manufactured in April 2024 and is set to expire in March 2026.
Accordingly, all the concerned medical officers have been instructed to stop using the identified batch with immediate effect.
Follow our WhatsApp channel
